C5 - Newborns Exposed Prenatally To Opiates: Demystifying The Myths Of NAS

1.00 Pharmacology Contact Hours


Title: C5 - Newborns Exposed Prenatally To Opiates: Demystifying The Myths Of NAS

Disciplines: Advanced Practice (AP), Childbearing (CB), Newborn Care (N)

Learning Objectives:
  1. Differentiate variations in timing of symptom onset of neonatal withdrawal from prenatal exposure to oxycodone and hydrocodone versus buprenorphine and methadone.
  2. Discuss reliable, consistent, and objective nursing assessment of neonatal abstinence syndrome utilizing definitions for scorers.
  3. Describe variations in pharmacologic and non pharmacologic interventions that improve care for the newborn experiencing withdrawal from opiates.
Submission Description:
Are you seeing an increase in newborns exposed to various opioids and derivatives (buprenorphine) who have become drug dependent? Explore methods of integrating reliable assessments and consistent creative nursing care for fragile infants who are drug addicted. This presentation will clarify the items most often misinterpreted on the Finnegan NAS and give you the knowledge to convert colleagues to utilize standardized definitions of the FNAS. Leave energized and ready to share new resources and assessment methods and champion consistent quality care.
Monday, June 17, 2013: 2:45 PM-3:45 PM
Cheekwood ABC (Gaylord Opryland)
Moderator:
Rita A. Haedicke, RNC, MSN, CNL, NE-BC
Presenting Author:
Maureen Shogan, MN, RNC
<< Previous Session | Next Session >>